MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
TORONTO, May 28, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (“MediPharm” or the “Company“), a pharmaceutical company specialized in precision-based cannabinoids, today issued a Letter to Shareholders from the Company’s Board of Directors (the “L…
Please remember to visit our AGM website at www.medipharmlabsagm.com for the most timely information.
We thank you for your support and look forward to hosting you on June 16, 2025.
Sincerely,
The…